Skip to content

Comparison of better pain control with Bupivacaine with Fentanyl versus Bupivacaine with Tramadol in spinal anaesthesia for Cesarean Section

Comparison of Efficacy of intrathecal tramadol versus intrathecal fentanyl as adjuvant to 0.5% Bupivacaine for post operative pain relief in elective cesarean section - Not applicable

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048547
Enrollment
104
Registered
2022-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O82- Encounter for cesarean delivery without indication

Interventions

Intervention1: Sub arachnoid block: Sub arachnoid block with 2.5 ml 0.5% Bupivacaine heavy with 25 mg tramadol Control Intervention1: Sub arachnoid block: Sub arachnoid block with 0.5% 2.5ml Bupivacai

Sponsors

College of medicine and Sagore Dutta Hospital
Lead Sponsor
Dept of Anaesthesia
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant mothers of age 20 to 40 years ASA Grade II. Enrolled for elective caesarean section

Exclusion criteria

Exclusion criteria: Age below 20 or above 40 years Infection at site of injection, any coagulopathy disorder or patients on anticoagulants, pre-existing neurological disease, psychological troubles, endocrinal disease Morbid obesity. Failure of spinal blockade. Patients with previous spinal surgery, kyphoscoliosis or any spinal deformity Emergency CS. Complicated pregnancy. Intrauterine fetal compromise Patients with known history of previous opioids abuse or allergic to opioids, allergy to local anaesthetic drugs, History of any neurological disease like Gullion Berry syndrome, sub-acute combined degeneration of spinal cord etc.

Design outcomes

Primary

MeasureTime frame
Better post operative pain management in Parturients receiving fentanyl as a adjuvant to hyperbaric bupivacaineTimepoint: Baseline, every 5min for for 1hour, then every 10min interval

Secondary

MeasureTime frame
Neonatal outcomeTimepoint: 1min and 5min

Countries

India

Contacts

Public ContactSudipta Saha

College of Medicine and Sagore Dutta Hospital

sudipta.saha367@gmail.com8697896573

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026